GlassScriptPhysician profile
Scott A Snyder
NPI 1255397972
$6,006.78
in general payments reported to CMS, 2019-2025
33 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $453 · 2021: $93.38 · 2022: $1,032 · 2023: $1,062 · 2024: $993 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,226 · Education: $137 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,225.68 |
| Education | $137.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $619.80 | 2019-2024 | |
| Aroa Biosurgery Incorporated | $601.64 | 2022-2023 | |
| Stryker Corporation | $468.14 | 2022-2025 | Spy-Phi System, Cascadia Interbody System |
| Csl Behring | $393.99 | 2020-2025 | Kcentra, Haegarda |
| Pacira Pharmaceuticals Incorporated | $373.11 | 2020-2023 | Iovera |
| Heron Therapeutics, INC. | $343.64 | 2022-2025 | Zynrelef, Aponvie |
| Merck Sharp & Dohme LLC | $279.14 | 2019-2024 | Bridion |
| Kerecis Limited | $250.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $211.63 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $177.35 | 2019-2024 | Caldolor |
| Atricure, INC. | $165.83 | 2024 | |
| Davol INC. | $164.65 | 2023-2024 | Phasix Mesh |
| Innovation Technologies INC | $163.80 | 2025 | Irrisept |
| Acumed LLC | $157.93 | 2023 | Ribloc |
| Solventum Corporation | $153.29 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Acell, INC. | $125.00 | 2019 | |
| Mallinckrodt Enterprises LLC | $124.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.24 | 2025 | Gattex |
| Covidien LP | $103.13 | 2019 | |
| Medline Industries LP | $99.82 | 2019 | |
| Janssen Biotech, INC. | $91.91 | 2023-2025 | Stelara, Tremfya, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $90.47 | 2019-2021 | |
| Abbvie INC. | $84.61 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $71.20 | 2024 | Voquezna |
| Redhill Biopharma INC. | $60.59 | 2020-2021 | |
| Intercept Pharmaceuticals, INC. | $37.83 | 2020-2025 | |
| Boston Scientific Corporation | $26.66 | 2020-2021 | |
| Celltrion USA INC. | $25.54 | 2024 | Vegzelma |
| Medtronic, INC. | $24.13 | 2024 | Becker |
| Exact Sciences Corporation | $21.21 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.